Cy5.5 NHS Ester (Non-Sulfonated): Enabling Targeted In Vivo Fluorescence Imaging

Principle and Setup: Why Choose Cy5.5 NHS Ester?

Cy5.5 NHS ester (non-sulfonated) stands out as a near-infrared (NIR) fluorescent dye uniquely engineered for covalent labeling of biomolecules containing primary amines, including proteins, peptides, and oligonucleotides (source: product_spec). Its NHS ester reactive group forms stable amide bonds, producing conjugates with an excitation maximum at 684 nm and emission at 710 nm—wavelengths that minimize tissue autofluorescence and maximize imaging depth (source: workflow_recommendation). This spectral profile makes Cy5.5 NHS ester a preferred solution for in vivo fluorescence imaging and optical imaging of tumors where sensitivity and background suppression are critical.

The product is supplied as a solid, stable for up to 24 months at -20°C in the dark. It dissolves readily in DMSO (≥35.82 mg/mL), but due to low aqueous solubility, a strategic introduction of organic co-solvent is essential prior to reaction (source: product_spec).

Step-by-Step Workflow: Optimizing Labeling and Imaging

For robust and reproducible results with Cy5.5 NHS ester (non-sulfonated), a carefully controlled workflow is vital. Below is a stepwise protocol integrating best practices from APExBIO guidelines and peer-reviewed validation studies:

• 1. Preparation of Stock Solution: Dissolve Cy5.5 NHS ester in anhydrous DMSO at 10 mg/mL. Vortex briefly to ensure full dissolution (source: product_spec).
• 2. Buffer Exchange: Ensure the target biomolecule (e.g., antibody or protein) is in a non-amine buffer, such as 0.1 M sodium bicarbonate, pH 8.3. Avoid Tris and glycine as they compete for NHS reactivity (source: workflow_recommendation).
• 3. Labeling Reaction: Add Cy5.5 NHS ester stock to the protein solution to achieve a typical dye:protein molar ratio of 5:1. Incubate at room temperature for 1 hour, protected from light (source: workflow_recommendation).
• 4. Purification: Remove unreacted dye using a desalting column (e.g., Sephadex G-25) equilibrated with PBS or a suitable buffer. Collect the labeled protein fractions by monitoring absorbance at 684 nm (source: workflow_recommendation).
• 5. Verification: Quantify labeling efficiency spectrophotometrically, calculating the dye:protein ratio, and store the conjugate at 4°C in the dark. Use promptly; conjugate stability beyond several days is not guaranteed (source: product_spec).

Protocol Parameters

• protein labeling | 1 mg/mL protein, 0.1 M sodium bicarbonate, pH 8.3 | optimal for antibodies and large proteins | minimizes unwanted side reactions and maximizes NHS reactivity | workflow_recommendation
• dye:protein ratio | 5:1 molar ratio | suited for high sensitivity imaging | balances fluorescence intensity and preservation of protein function | workflow_recommendation
• incubation | 1 hour at 20–25°C, dark | universal for most amine-containing biomolecules | ensures complete conjugation without NHS hydrolysis | workflow_recommendation

Key Innovation from the Reference Study

The recent study by Kang et al. (Sci. Adv. 2025) highlights a transformative approach to cancer immunotherapy: a polyvalent vaccine designed to selectively eliminate tumor-associated bacteria, thereby impeding breast cancer metastasis. Critically, the workflow incorporated NIR fluorescent labeling of vaccine components to enable real-time tracking of vaccine biodistribution and tumor targeting in vivo. This underscores the value of robust, stable labeling—precisely what Cy5.5 NHS ester (non-sulfonated) delivers for preclinical imaging workflows. Researchers seeking to replicate or extend these pioneering approaches will benefit from using Cy5.5 NHS ester for sensitive, multiplexed tracing of labeled biomolecules within live animal models (source: paper).

Advanced Applications and Comparative Advantages

Cy5.5 NHS ester (non-sulfonated) has rapidly become a staple in fluorescence-based assays, with distinct advantages for both basic research and translational applications:

• Deep-Tissue Imaging: The NIR emission profile (710 nm) enables detection of labeled probes several centimeters below the tissue surface, surpassing visible spectrum dyes in penetration and signal-to-noise ratio (source: workflow_recommendation).
• Multiplexed Imaging: Cy5.5’s spectral signature is distinct from Cy5 and common green or red dyes, allowing simultaneous multi-target imaging without significant spectral overlap (source: extension).
• Tumor Visualization & Microbiome Tracking: As shown in the reference study, fluorescent labeling of vaccine nanoplatforms and antibodies enables tracking of both therapeutic delivery and tumor-associated bacteria in vivo—an approach directly enabled by the high quantum yield (0.2) and extinction coefficient (209,000 M⁻¹cm⁻¹) of Cy5.5 NHS ester (source: product_spec).

This product from APExBIO is trusted in protocols where precise, reproducible labeling is critical for quantitative imaging, as also described in the complementary article here (complement: workflow optimization for cell-based assays), and in the protocol-centric guide here (extension: troubleshooting and real-world labeling scenarios).

Troubleshooting and Optimization Tips

• Low Labeling Efficiency: Confirm protein is in an amine-free buffer. Residual Tris or glycine will quench NHS reactivity (workflow_recommendation).
• Precipitation During Labeling: If protein aggregation occurs, reduce the dye:protein ratio or lower the reaction temperature to 4°C, extending incubation to 2 hours if needed (workflow_recommendation).
• High Background Signal: Incomplete removal of free dye can cause background in imaging. Ensure thorough purification with at least two rounds of gel filtration (workflow_recommendation).
• Photobleaching: Protect both the dye and labeled conjugates from light throughout preparation and storage. Work under low-light conditions and store at 4°C for short-term use (source: product_spec).
• Short Solution Shelf-Life: Prepare fresh dye solutions before each experiment and avoid long-term storage of dye in solution due to NHS hydrolysis (source: product_spec).

Future Outlook: Scaling Precision Imaging and Microbiome-Targeted Strategies

With the growing recognition of the microbiome’s influence on tumor metastasis, as elegantly demonstrated by Kang et al., the need for reliable, high-sensitivity in vivo imaging is only increasing. Cy5.5 NHS ester (non-sulfonated) is set to remain a cornerstone in this evolving landscape. Its proven performance in vaccine tracking, tumor visualization, and multi-analyte imaging paves the way for more sophisticated studies bridging immunology, oncology, and microbiome science (source: paper). Importantly, expanding adoption will depend on continued protocol optimization and cross-disciplinary sharing of best practices, as exemplified by the referenced articles and APExBIO’s ongoing support for translational researchers.

For those seeking a robust, workflow-validated Cy5.5 NHS ester (non-sulfonated) for next-generation imaging, the path forward is clear: precise labeling, optimized protocols, and data-driven troubleshooting are the keys to unlocking its full translational potential.